• By ICR Secretariat
  • Posted Wednesday, July 21, 2021

Biohaven CEO on migraine drug's fast launch, TikTok ads and battling big pharma

https://www.biopharmadive.com/news/biohaven-coric-nurtec-migraine-marketing/603252/

Migraine sufferers in the U.S. found some relief over the past few years as a handful of new treatments came to market. The additions include a group of injectable drugs that help prevent the painful headaches, as well as a pill, Ubrelvy, which was cleared in late 2019 to alleviate migraines after they start.